Perreau et al. and others reported that HGF expression levels could predict the severity of COVID-19 and that HGF could contribute to alleviating lung injury by suppressing the transforming growth factor-beta (TGF-β) signaling pathway [101–103]. This evidence concerns the gene HGF and COVID-19.